A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- Innoviva Specialty Therapeutics
- Study ID
- NCT06746883
- Status
- Recruiting
Conditions
- Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-interventional — OTHERNon-interventional
Study Details
The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.
Key Dates
- Start date
- Apr 28, 2025
- Status verified
- May 2026
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Acinetobacter baumannii-calcoaceticus complex (ABC)Hospitalized participants with a proven or strongly suspected ABC infection who have received sulbactam-durlobactam as standard of care.
Primary Outcome Measure
Percentage of participants experiencing Treatment Emergent Adverse Events (TEAEs) defined as any event after exposure to sulbactam-durlobactam (SUL-DUR), or event already present that worsens in either intensity or frequency after exposure [ Time Frame: 28 days ]
Central Contacts
- Reddy Tummala ISTX Clinical Trials617-715-3600
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Florida - Gainesville | Gainesville | Florida | 32610-3003 | - |
| University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd | Kansas City | Kansas | 66160 | - |
| University of Kentucky College of Medicine | Lexington | Kentucky | 40536-7001 | - |
| Ochsner Medical Center - New Orleans | New Orleans | Louisiana | 70121-2429 | - |
| Ochsner LSU Health Science Center Shreveport | Shreveport | Louisiana | 71103-4228 | - |
| Montefiore Medical Group Family Care Center | The Bronx | New York | 10467-2410 | - |
| Summa Health System - Akron - 75 Arch Street | Akron | Ohio | 44304-1430 | - |
| The Carl and Edyth Lindner Center for Research and Education at Christ Hospital | Cincinnati | Ohio | 45219 | - |
| University of Pittsburg School of Medicine | Pittsburgh | Pennsylvania | 15213-2500 | - |
| Prisma Health - Infectious Diseases - Greenville | Greenville | South Carolina | 29605 | - |
Find similar trials in Gainesville, FL
By research site
University of Florida - Gainesville· Gainesville, FLUniversity of Kansas Medical Center-Kansas City-3901 Rainbow Blvd· Kansas City, KSUniversity of Kentucky College of Medicine· Lexington, KYOchsner Medical Center - New Orleans· New Orleans, LAOchsner LSU Health Science Center Shreveport· Shreveport, LAMontefiore Medical Group Family Care Center· The Bronx, NY
Related Studies
- A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex InfectionPHASE1 · Recruiting · Innoviva Specialty Therapeutics · Los Angeles, California